Open AccessCD103+ T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer
Author(s) -
Takuya Mori,
Hiroaki Tanaka,
Sota Deguchi,
Yuichiro Miki,
Mami Yoshii,
Tatsuro Tajiri,
Takahiro Toyokawa,
SHIGERU LEE,
Kazuya Muguruma,
Masaichi Ohira
Publication year - 2022
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10121
Subject(s) - immunohistochemistry , cancer , biomarker , staining , medicine , antigen , pathology , cancer research , gastroenterology , biology , immunology , biochemistry
Recently, several studies have reported that CD103 + T cells are associated with antitumor immunity in gastric cancer (GC). However, the significance of CD103 + T cells in Borrmann type 4 GC remains unclear. The aim of this study is to assess the association of CD103 + T cells with type 4 GC.